抗脂抗体和动脉样性血管疾病:最近的进展
Anetta Undas1,2, Jacek Musiał3,4, Michał Ząbczyk5,6
1Department of Thromboembolic Diseases, Institute of Cardiology, Jagiellonian University Medical College, Pradnicka 80, 31-202, Krakow, Poland. mmundas@cyf-kr.edu.pl.
Rheumatology international
|November 29, 2025
概括
抗脂抗体 (aPL) 加快动脉样硬化和动脉血栓形成,即使没有抗脂综合征 (APS). 对心血管风险因素的有力治疗对于aPL患者至关重要.
科学领域:
- 心血管医学 心血管医学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 抗脂抗体 (aPL) 与动脉血栓形成和加速动脉样硬化有关.
- 抗脂综合征 (APS) 加剧动脉样硬化血管疾病,特别是与共存的自身免疫性疾病,如SLE.
- 单独存在aPL可能会增加不符合APS标准的老年人的动脉样硬化和动脉血栓栓塞风险.
研究的目的:
- 审查关于aPL在亚临床和明显动脉样硬化血管疾病中的作用的临床证据.
- 讨论aPL相关动脉样硬化和血栓形成的管理策略.
主要方法:
- 临床研究和证据的文献综述.
- 分析传统心血管风险因素对aPL相关疾病的影响.
- 评估目前用于预防APS的动脉血栓形成的治疗策略.
主要成果:
- aPL有助于早期动脉样硬化和各种动脉的狭窄病变.
- 同时存在的SLE或其他自身免疫性疾病与APS加速动脉样硬化血管疾病.
- 高血压和高胆固醇血症对aPL患者的心血管疾病进展有显著的贡献.
- 抗血小板剂和VKA仍然是预防APS动脉血栓形成的关键.
结论:
- aPL在亚临床和临床动脉样硬化血管疾病中起着重要作用.
- 在aPL患者中,对传统心血管风险因素的积极管理至关重要.
- 在aPL中动脉血栓的治疗策略需要仔细考虑动脉样硬化负担和风险因素.
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
424
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
424
Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Peripheral Artery Disease I: Introduction
275
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
275
Atherosclerosis I: Introduction
738
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
738
Coronary Artery Disease I: Introduction
843
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
843
Peripheral Artery Disease III: Interprofessional Care
215
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
215


